Uncategorized

Man awarded $412m after ‘invasive erectile dysfunction shots’ that caused irreversible damage

According to the complaint, the man, aged 66 at the time, visited a NuMale Medical Center health clinic in 2017 in search of treatment for fatigue and weight loss, but was misdiagnosed and given “invasive erectile dysfunction shots”.

A man has been awarded $412m (£325m) in damages after a US clinic gave him “invasive erectile dysfunction shots” that caused him irreversible harm.

Jurors in New Mexico awarded the man the record damages after he fell victim to a scheme that involved fraud and the dangerous injections.

According to the complaint against NuMale Medical Center and its company officials, in 2017 the then 66-year-old visited a clinic in search of help for fatigue and weight loss.

The clinic is accused of misdiagnosing him and unnecessarily giving him the “invasive erectile dysfunction shots”.

Lori Bencoe, one of the man’s attorneys, said: “It [the damages] is a national record setting case and it’s righteous because I don’t think there’s any place for licensed professionals to be defrauding patients for money.

“That is a very egregious breach of their fiduciary duty.

“That’s breach of trust and anytime someone is wearing a white coat, they shouldn’t be allowed to do that.”

The award follows a trial held in Albuquerque earlier this month that focused on allegations outlined in a 2020 lawsuit.

In a statement, NuMale Medical said its priority was delivering patient care, adding: “While we respect the judicial process, due to ongoing legal proceedings, we cannot comment on specific details of the case at this time.”

NuMale also has clinics in Colorado, Florida, Illinois, Nevada, Nebraska, North Carolina and Wisconsin.

According to court records, jurors found that fraudulent and negligent conduct by the defendants resulted in damages to the plaintiff.

They also found that unconscionable conduct by the defendants violated the Unfair Practices Act.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button